Clinical Trial Update: Palonestron, Granisetron and Ramosetron for Prevention of Postoperative Nasea and Voming After Laparoscopic Abdominal Surgery

View source ↗

Summary

Clinical trial NCT01752374 evaluates palonosetron, granisetron, and ramosetron for prevention of postoperative nausea and vomiting after laparoscopic abdominal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Granisetron (granisetron)
• Palonosetron (palonosetron)
• Ramosetron (ramosetron)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Female Patients Undergoing Laparoscopic Abdominal Surgery | Status: COMPLETED